Literature DB >> 19436582

The effect of a low molecular weight heparin on coagulation parameters in healthy cats.

Cheryl L Vargo1, Susan M Taylor, Anthony Carr, Marion L Jackson.   

Abstract

The low molecular weight heparin (LMWH), dalteparin sodium, was administered subcutaneously (100 IU/kg) to 8 healthy cats twice daily for 13 doses. Anti-activated factor X (anti-Xa) activity was measured prior to administration (time 0), and 4, 6, 8, and 12 h after the 1st dose, 4 h after administration of the 3rd dose, and at 4, 6, 8, and 12 h after the last dose. Four cats developed measurable anti-Xa activity 4 h following a single dose, returning to baseline by 6 h. Anti-Xa activity was not detected at any time point in 4 cats. Prothrombin time (PT), activated partial thromboplastin time (APTT), and antithrombin (AT) concentrations were unaffected by LMWH administration. Dalteparin, at 100 IU/kg SC, did not achieve anti-Xa activity in 4 out of 8 cats and failed to maintain anti-Xa activity beyond 4 h in the other 4 healthy cats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436582      PMCID: PMC2666318     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  14 in total

1.  The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.

Authors:  R Mischke; S Grebe
Journal:  Res Vet Sci       Date:  2000-12       Impact factor: 2.534

2.  [Phamacokinetics of low-molecular-weight heparins Fragmin D in dogs].

Authors:  S Grebe; C Jacobs; M Kietzmann; R Mischke
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2000-03       Impact factor: 0.328

3.  Amidolytic heparin activity and values for several hemostatic variables after repeated subcutaneous administration of high doses of a low molecular weight heparin in healthy dogs.

Authors:  R Mischke; S Grebe; C Jacobs; M Kietzmann
Journal:  Am J Vet Res       Date:  2001-04       Impact factor: 1.156

4.  Reference values for activated coagulation time in cats.

Authors:  J D Bay; M A Scott; J E Hans
Journal:  Am J Vet Res       Date:  2000-07       Impact factor: 1.156

5.  Use of low molecular weight heparin in cats: 57 cases (1999-2003).

Authors:  Caren E Smith; Elizabeth A Rozanski; Lisa M Freeman; Donald J Brown; Jennifer S Goodman; John E Rush
Journal:  J Am Vet Med Assoc       Date:  2004-10-15       Impact factor: 1.936

Review 6.  An update on heparins at the beginning of the new millennium.

Authors:  J Fareed; D A Hoppensteadt; R L Bick
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

7.  [Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity].

Authors:  C Jacobs; S Grebe; M Kietzmann; R Mischke
Journal:  Dtsch Tierarztl Wochenschr       Date:  1999-11

8.  Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs.

Authors:  R H Mischke; C Schüttert; S I Grebe
Journal:  Am J Vet Res       Date:  2001-12       Impact factor: 1.156

Review 9.  Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Authors:  J Hirsh; T E Warkentin; R Raschke; C Granger; E M Ohman; J E Dalen
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

10.  Anticoagulant effects of low-molecular-weight heparins in healthy cats.

Authors:  Amy J Alwood; Amanda B Downend; Marjory B Brooks; Kimberly A Slensky; Julia A Fox; Stephen A Simpson; Lori S Waddell; James E Baumgardner; Cynthia M Otto
Journal:  J Vet Intern Med       Date:  2007 May-Jun       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.